Gender and disease-inclusive nomenclature consolidation of theragnostic target, prostate-specific membrane antigen (PSMA) to folate hydrolase-1 (FOLH1)
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-02-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2023.1304718/full |
| _version_ | 1797302046264655872 |
|---|---|
| author | Marigdalia K. Ramirez-Fort Marigdalia K. Ramirez-Fort Marigdalia K. Ramirez-Fort Casey K. Gilman Casey K. Gilman Jacob S. Alexander Jacob S. Alexander Barbara Meier-Schiesser Arjan Gower Mojtaba Olyaie Mojtaba Olyaie Neel Vaidya Kiarash Vahidi Yuxin Li Yuxin Li Christopher S. Lange Christopher S. Lange Migdalia Fort Corinne Deurdulian Corinne Deurdulian Corinne Deurdulian |
| author_facet | Marigdalia K. Ramirez-Fort Marigdalia K. Ramirez-Fort Marigdalia K. Ramirez-Fort Casey K. Gilman Casey K. Gilman Jacob S. Alexander Jacob S. Alexander Barbara Meier-Schiesser Arjan Gower Mojtaba Olyaie Mojtaba Olyaie Neel Vaidya Kiarash Vahidi Yuxin Li Yuxin Li Christopher S. Lange Christopher S. Lange Migdalia Fort Corinne Deurdulian Corinne Deurdulian Corinne Deurdulian |
| author_sort | Marigdalia K. Ramirez-Fort |
| collection | DOAJ |
| first_indexed | 2024-03-07T23:31:12Z |
| format | Article |
| id | doaj.art-0661bd57fef3484996f9523bd2db55ea |
| institution | Directory Open Access Journal |
| issn | 2296-858X |
| language | English |
| last_indexed | 2024-03-07T23:31:12Z |
| publishDate | 2024-02-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Medicine |
| spelling | doaj.art-0661bd57fef3484996f9523bd2db55ea2024-02-20T13:11:48ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2024-02-011010.3389/fmed.2023.13047181304718Gender and disease-inclusive nomenclature consolidation of theragnostic target, prostate-specific membrane antigen (PSMA) to folate hydrolase-1 (FOLH1)Marigdalia K. Ramirez-Fort0Marigdalia K. Ramirez-Fort1Marigdalia K. Ramirez-Fort2Casey K. Gilman3Casey K. Gilman4Jacob S. Alexander5Jacob S. Alexander6Barbara Meier-Schiesser7Arjan Gower8Mojtaba Olyaie9Mojtaba Olyaie10Neel Vaidya11Kiarash Vahidi12Yuxin Li13Yuxin Li14Christopher S. Lange15Christopher S. Lange16Migdalia Fort17Corinne Deurdulian18Corinne Deurdulian19Corinne Deurdulian20BioFort, Guaynabo, Puerto RicoVeterans Affairs (VA) Greater Los Angeles Healthcare System, Veterans Health Administration, United States Department of Veterans Affairs, Los Angeles, CA, United StatesUniversity of California at Los Angeles (UCLA) Health System, Los Angeles, CA, United StatesBioFort, Guaynabo, Puerto RicoSan Juan Bautista School of Medicine, Caguas, Puerto RicoBioFort, Guaynabo, Puerto RicoSan Juan Bautista School of Medicine, Caguas, Puerto RicoUniversity Hospital Zürich, Zürich, SwitzerlandUniversity of California at Los Angeles (UCLA) Health System, Los Angeles, CA, United StatesVeterans Affairs (VA) Greater Los Angeles Healthcare System, Veterans Health Administration, United States Department of Veterans Affairs, Los Angeles, CA, United StatesUniversity of California at Los Angeles (UCLA) Health System, Los Angeles, CA, United StatesVeterans Affairs (VA) Greater Los Angeles Healthcare System, Veterans Health Administration, United States Department of Veterans Affairs, Los Angeles, CA, United StatesVeterans Affairs (VA) Greater Los Angeles Healthcare System, Veterans Health Administration, United States Department of Veterans Affairs, Los Angeles, CA, United StatesVeterans Affairs (VA) Greater Los Angeles Healthcare System, Veterans Health Administration, United States Department of Veterans Affairs, Los Angeles, CA, United StatesUniversity of California at Los Angeles (UCLA) Health System, Los Angeles, CA, United StatesBioFort, Guaynabo, Puerto RicoDepartment of Radiology, SUNY Downstate Health Sciences University, Brooklyn, NY, United StatesBioFort, Guaynabo, Puerto RicoVeterans Affairs (VA) Greater Los Angeles Healthcare System, Veterans Health Administration, United States Department of Veterans Affairs, Los Angeles, CA, United StatesUniversity of California at Los Angeles (UCLA) Health System, Los Angeles, CA, United StatesUniversity of Southern California, Los Angeles, CA, United Stateshttps://www.frontiersin.org/articles/10.3389/fmed.2023.1304718/fullfolate hydrolase-1prostate-specific membrane antigentheragnostic targetgender-inclusive languagedisease-inclusive language |
| spellingShingle | Marigdalia K. Ramirez-Fort Marigdalia K. Ramirez-Fort Marigdalia K. Ramirez-Fort Casey K. Gilman Casey K. Gilman Jacob S. Alexander Jacob S. Alexander Barbara Meier-Schiesser Arjan Gower Mojtaba Olyaie Mojtaba Olyaie Neel Vaidya Kiarash Vahidi Yuxin Li Yuxin Li Christopher S. Lange Christopher S. Lange Migdalia Fort Corinne Deurdulian Corinne Deurdulian Corinne Deurdulian Gender and disease-inclusive nomenclature consolidation of theragnostic target, prostate-specific membrane antigen (PSMA) to folate hydrolase-1 (FOLH1) Frontiers in Medicine folate hydrolase-1 prostate-specific membrane antigen theragnostic target gender-inclusive language disease-inclusive language |
| title | Gender and disease-inclusive nomenclature consolidation of theragnostic target, prostate-specific membrane antigen (PSMA) to folate hydrolase-1 (FOLH1) |
| title_full | Gender and disease-inclusive nomenclature consolidation of theragnostic target, prostate-specific membrane antigen (PSMA) to folate hydrolase-1 (FOLH1) |
| title_fullStr | Gender and disease-inclusive nomenclature consolidation of theragnostic target, prostate-specific membrane antigen (PSMA) to folate hydrolase-1 (FOLH1) |
| title_full_unstemmed | Gender and disease-inclusive nomenclature consolidation of theragnostic target, prostate-specific membrane antigen (PSMA) to folate hydrolase-1 (FOLH1) |
| title_short | Gender and disease-inclusive nomenclature consolidation of theragnostic target, prostate-specific membrane antigen (PSMA) to folate hydrolase-1 (FOLH1) |
| title_sort | gender and disease inclusive nomenclature consolidation of theragnostic target prostate specific membrane antigen psma to folate hydrolase 1 folh1 |
| topic | folate hydrolase-1 prostate-specific membrane antigen theragnostic target gender-inclusive language disease-inclusive language |
| url | https://www.frontiersin.org/articles/10.3389/fmed.2023.1304718/full |
| work_keys_str_mv | AT marigdaliakramirezfort genderanddiseaseinclusivenomenclatureconsolidationoftheragnostictargetprostatespecificmembraneantigenpsmatofolatehydrolase1folh1 AT marigdaliakramirezfort genderanddiseaseinclusivenomenclatureconsolidationoftheragnostictargetprostatespecificmembraneantigenpsmatofolatehydrolase1folh1 AT marigdaliakramirezfort genderanddiseaseinclusivenomenclatureconsolidationoftheragnostictargetprostatespecificmembraneantigenpsmatofolatehydrolase1folh1 AT caseykgilman genderanddiseaseinclusivenomenclatureconsolidationoftheragnostictargetprostatespecificmembraneantigenpsmatofolatehydrolase1folh1 AT caseykgilman genderanddiseaseinclusivenomenclatureconsolidationoftheragnostictargetprostatespecificmembraneantigenpsmatofolatehydrolase1folh1 AT jacobsalexander genderanddiseaseinclusivenomenclatureconsolidationoftheragnostictargetprostatespecificmembraneantigenpsmatofolatehydrolase1folh1 AT jacobsalexander genderanddiseaseinclusivenomenclatureconsolidationoftheragnostictargetprostatespecificmembraneantigenpsmatofolatehydrolase1folh1 AT barbarameierschiesser genderanddiseaseinclusivenomenclatureconsolidationoftheragnostictargetprostatespecificmembraneantigenpsmatofolatehydrolase1folh1 AT arjangower genderanddiseaseinclusivenomenclatureconsolidationoftheragnostictargetprostatespecificmembraneantigenpsmatofolatehydrolase1folh1 AT mojtabaolyaie genderanddiseaseinclusivenomenclatureconsolidationoftheragnostictargetprostatespecificmembraneantigenpsmatofolatehydrolase1folh1 AT mojtabaolyaie genderanddiseaseinclusivenomenclatureconsolidationoftheragnostictargetprostatespecificmembraneantigenpsmatofolatehydrolase1folh1 AT neelvaidya genderanddiseaseinclusivenomenclatureconsolidationoftheragnostictargetprostatespecificmembraneantigenpsmatofolatehydrolase1folh1 AT kiarashvahidi genderanddiseaseinclusivenomenclatureconsolidationoftheragnostictargetprostatespecificmembraneantigenpsmatofolatehydrolase1folh1 AT yuxinli genderanddiseaseinclusivenomenclatureconsolidationoftheragnostictargetprostatespecificmembraneantigenpsmatofolatehydrolase1folh1 AT yuxinli genderanddiseaseinclusivenomenclatureconsolidationoftheragnostictargetprostatespecificmembraneantigenpsmatofolatehydrolase1folh1 AT christopherslange genderanddiseaseinclusivenomenclatureconsolidationoftheragnostictargetprostatespecificmembraneantigenpsmatofolatehydrolase1folh1 AT christopherslange genderanddiseaseinclusivenomenclatureconsolidationoftheragnostictargetprostatespecificmembraneantigenpsmatofolatehydrolase1folh1 AT migdaliafort genderanddiseaseinclusivenomenclatureconsolidationoftheragnostictargetprostatespecificmembraneantigenpsmatofolatehydrolase1folh1 AT corinnedeurdulian genderanddiseaseinclusivenomenclatureconsolidationoftheragnostictargetprostatespecificmembraneantigenpsmatofolatehydrolase1folh1 AT corinnedeurdulian genderanddiseaseinclusivenomenclatureconsolidationoftheragnostictargetprostatespecificmembraneantigenpsmatofolatehydrolase1folh1 AT corinnedeurdulian genderanddiseaseinclusivenomenclatureconsolidationoftheragnostictargetprostatespecificmembraneantigenpsmatofolatehydrolase1folh1 |